Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Complete loss of HLA class I antigen expression on melanoma cells: A result of successive mutational events
Annette Paschen, Rosa Méndez, Pilar Jiménez, et al.
International Journal of Cancer (2002) Vol. 103, Iss. 6, pp. 759-767
Open Access | Times Cited: 97

Showing 1-25 of 97 citing articles:

“Hard” and “soft” lesions underlying the HLA class I alterations in cancer cells: Implications for immunotherapy
Federico Garrido, Teresa Cabrera, Natalia Aptsiauri
International Journal of Cancer (2010) Vol. 127, Iss. 2, pp. 249-256
Open Access | Times Cited: 258
Deregulation of HLA-I in cancer and its central importance for immunotherapy
Ahmet Hazini, Kerry Fisher, Leonard W. Seymour
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 8, pp. e002899-e002899
Open Access | Times Cited: 137
Differential Clinical Significance of Individual NKG2D Ligands in Melanoma: Soluble ULBP2 as an Indicator of Poor Prognosis Superior to S100B
Annette Paschen, Antje Sucker, Bettina Hill, et al.
Clinical Cancer Research (2009) Vol. 15, Iss. 16, pp. 5208-5215
Open Access | Times Cited: 181
Genetic Evolution of T-cell Resistance in the Course of Melanoma Progression
Antje Sucker, Fang Zhao, Birgit Real, et al.
Clinical Cancer Research (2014) Vol. 20, Iss. 24, pp. 6593-6604
Open Access | Times Cited: 158
Molecular mechanisms of MHC class I abnormalities and APM components in human tumors
Barbara Seliger
Cancer Immunology Immunotherapy (2008) Vol. 57, Iss. 11, pp. 1719-1726
Open Access | Times Cited: 146
Immune escape of cancer cells with beta2‐microglobulin loss over the course of metastatic melanoma
Ana Belén Campo, Jon Amund Kyte, Javier Carretero, et al.
International Journal of Cancer (2013) Vol. 134, Iss. 1, pp. 102-113
Open Access | Times Cited: 137
Intranasal mRNA nanoparticle vaccination induces prophylactic and therapeutic anti-tumor immunity
Kyle K.L. Phua, Herman F. Staats, Kam W. Leong, et al.
Scientific Reports (2014) Vol. 4, Iss. 1
Open Access | Times Cited: 115
Implication of the β2-microglobulin gene in the generation of tumor escape phenotypes
Mónica Bernal, Francisco Ruiz‐Cabello, Ángel Concha, et al.
Cancer Immunology Immunotherapy (2012) Vol. 61, Iss. 9, pp. 1359-1371
Closed Access | Times Cited: 107
The transition from HLA-I positive to HLA-I negative primary tumors: the road to escape from T-cell responses
Natalia Aptsiauri, Francisco Ruiz‐Cabello, Federico Garrido
Current Opinion in Immunology (2018) Vol. 51, pp. 123-132
Closed Access | Times Cited: 101
MHC Class I Antigens and Immune Surveillance in Transformed Cells
Natalia Aptsiauri, Teresa Cabrera, Ángel M. García-Lora, et al.
International review of cytology (2007), pp. 139-189
Closed Access | Times Cited: 139
Role of Altered Expression of HLA Class I Molecules in Cancer Progression
Natalia Aptsiauri, Teresa Cabrera, Rosa Méndez, et al.
Advances in experimental medicine and biology (2007), pp. 123-131
Closed Access | Times Cited: 131
Systemic Delivery ofSalmonella typhimuriumTransformed with IDO shRNA Enhances Intratumoral Vector Colonization and Suppresses Tumor Growth
Céline A. Blache, Edwin R. Manuel, Teodora Kaltcheva, et al.
Cancer Research (2012) Vol. 72, Iss. 24, pp. 6447-6456
Open Access | Times Cited: 93
The absence of HLA class I expression in non‐small cell lung cancer correlates with the tumor tissue structure and the pattern of T cell infiltration
Francisco Perea, Mónica Bernal, Abel Sánchez‐Palencia, et al.
International Journal of Cancer (2016) Vol. 140, Iss. 4, pp. 888-899
Open Access | Times Cited: 84
The Escape of Cancer from T Cell-Mediated Immune Surveillance: HLA Class I Loss and Tumor Tissue Architecture
Federico Garrido, Francisco Perea, Mónica Bernal, et al.
Vaccines (2017) Vol. 5, Iss. 1, pp. 7-7
Open Access | Times Cited: 79
HLA class I loss and PD-L1 expression in lung cancer: impact on T-cell infiltration and immune escape
Francisco Perea, Abel Sánchez‐Palencia, Mercedes Gómez‐Morales, et al.
Oncotarget (2017) Vol. 9, Iss. 3, pp. 4120-4133
Open Access | Times Cited: 78
NLRC5/CITA: A Key Player in Cancer Immune Surveillance
Sayuri Yoshihama, Saptha Vijayan, Tabasum Sidiq, et al.
Trends in cancer (2017) Vol. 3, Iss. 1, pp. 28-38
Open Access | Times Cited: 74
LOH in the HLA Class I Region at 6p21 Is Associated with Shorter Survival in Newly Diagnosed Adult Glioblastoma
Jacky T. Yeung, Ronald L. Hamilton, Koji Ohnishi, et al.
Clinical Cancer Research (2013) Vol. 19, Iss. 7, pp. 1816-1826
Open Access | Times Cited: 72
Melanoma Lesions Independently Acquire T-cell Resistance during Metastatic Latency
Fang Zhao, Antje Sucker, Susanne Horn, et al.
Cancer Research (2016) Vol. 76, Iss. 15, pp. 4347-4358
Open Access | Times Cited: 67
Non-classical HLA-class I expression in serous ovarian carcinoma: Correlation with the HLA-genotype, tumor infiltrating immune cells and prognosis
Emilia Andersson, Isabel Poschke, Lisa Villabona, et al.
OncoImmunology (2015) Vol. 5, Iss. 1, pp. e1052213-e1052213
Open Access | Times Cited: 66
MHC/HLA Class I Loss in Cancer Cells
Federico Garrido
Advances in experimental medicine and biology (2019), pp. 15-78
Closed Access | Times Cited: 65
Deciphering the complexities of cancer cell immune evasion: Mechanisms and therapeutic implications
Ishita Gupta, Ola Hussein, Konduru S. Sastry, et al.
Advances in Cancer Biology - Metastasis (2023) Vol. 8, pp. 100107-100107
Open Access | Times Cited: 19
NKG2A Is a Therapeutic Vulnerability in Immunotherapy Resistant MHC-I Heterogeneous Triple-Negative Breast Cancer
Brandie C. Taylor, Xiaopeng Sun, Paula I. González-Ericsson, et al.
Cancer Discovery (2023) Vol. 14, Iss. 2, pp. 290-307
Open Access | Times Cited: 18
Cutaneous melanoma susceptibility and progression genes
F DESNOO, Nicholas K. Hayward
Cancer Letters (2005) Vol. 230, Iss. 2, pp. 153-186
Closed Access | Times Cited: 112
Rationale for Antiangiogenic Cancer Therapy with Vaccination Using Epitope Peptides Derived from Human Vascular Endothelial Growth Factor Receptor 2
Satoshi Wada, Takuya Tsunoda, Toshiyuki Baba, et al.
Cancer Research (2005) Vol. 65, Iss. 11, pp. 4939-4946
Closed Access | Times Cited: 102
Interferon‐γ down‐regulates NKG2D ligand expression and impairs the NKG2D‐mediated cytolysis of MHC class I‐deficient melanoma by natural killer cells
Nicole Schwinn, Daria Vokhminova, Antje Sucker, et al.
International Journal of Cancer (2008) Vol. 124, Iss. 7, pp. 1594-1604
Open Access | Times Cited: 95
Page 1 - Next Page

Scroll to top